NYSE:ZBH - Zimmer Biomet Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $179.91
  • Forecasted Upside: 10.05 %
  • Number of Analysts: 20
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 14 Buy Ratings
  • 3 Strong Buy Ratings
$163.48
▲ +4.97 (3.14%)

This chart shows the closing price for ZBH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Zimmer Biomet Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZBH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZBH

Analyst Price Target is $179.91
▲ +10.05% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for Zimmer Biomet in the last 3 months. The average price target is $179.91, with a high forecast of $210.00 and a low forecast of $106.00. The average price target represents a 10.05% upside from the last price of $163.48.

This chart shows the closing price for ZBH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 20 investment analysts is to buy stock in Zimmer Biomet. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 2 strong buy ratings
  • 16 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/29/2019
  • 3 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/28/2020
  • 3 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/26/2020
  • 3 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/24/2020
  • 3 strong buy ratings
  • 17 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/23/2020
  • 3 strong buy ratings
  • 16 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/23/2021
  • 3 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 1 sell ratings
5/22/2021
  • 3 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/21/2021

Latest Recommendations

  • 3 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/25/2021BarclaysInitiated CoverageOverweight$210.00Low
5/17/2021JMP SecuritiesBoost Price TargetMarket Outperform$180.00 ➝ $195.00N/A
5/11/2021JMP SecuritiesBoost Price TargetOutperform$180.00 ➝ $195.00High
5/5/2021Truist SecuritiesBoost Price Target$174.00 ➝ $188.00Low
5/5/2021TruistBoost Price Target$174.00 ➝ $188.00Low
5/5/2021Canaccord GenuityBoost Price TargetBuy$189.00 ➝ $190.00Medium
5/5/2021Raymond JamesBoost Price TargetStrong-Buy$187.00 ➝ $200.00Low
5/5/2021SVB LeerinkBoost Price TargetOutperform$200.00 ➝ $205.00Low
5/5/2021OppenheimerBoost Price TargetOutperform$185.00 ➝ $195.00Low
4/15/2021Northland SecuritiesUpgradeMarket Perform ➝ Outperform$165.00 ➝ $200.00High
4/9/2021Northland SecuritiesUpgradeMarket Perform ➝ OutperformHigh
3/8/2021OppenheimerBoost Price TargetOutperform$173.00 ➝ $185.00Medium
3/1/2021Wells Fargo & CompanyBoost Price TargetOverweight$176.00 ➝ $183.00Low
2/8/2021Morgan StanleyBoost Price TargetOverweight$170.00 ➝ $180.00Low
2/8/2021Raymond JamesBoost Price TargetStrong-Buy$170.00 ➝ $187.00Low
2/8/2021Wells Fargo & CompanyBoost Price TargetOverweight$165.00 ➝ $176.00Low
2/8/2021SVB LeerinkBoost Price TargetPositive ➝ Outperform$185.00 ➝ $190.00Low
2/8/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$146.00 ➝ $160.00Low
2/5/2021Needham & Company LLCBoost Price TargetStrong-Buy$185.00 ➝ $192.00Low
2/5/2021OppenheimerInitiated CoverageBuy$173.00Low
2/5/2021Piper SandlerBoost Price TargetOverweight$185.00 ➝ $195.00Medium
1/27/2021JMP SecuritiesBoost Price TargetOutperform$165.00 ➝ $180.00High
1/25/2021BTIG ResearchBoost Price TargetBuy$160.00 ➝ $173.00Medium
1/8/2021Piper SandlerBoost Price TargetOverweight$160.00 ➝ $185.00Low
1/6/2021Truist FinancialBoost Price Target$152.00 ➝ $174.00N/A
1/4/2021Evercore ISIUpgradeIn-Line ➝ Outperform$175.00N/A
12/24/2020ArgusBoost Price TargetBuy$160.00 ➝ $170.00N/A
12/24/2020Raymond JamesReiterated RatingBuy$170.00N/A
12/18/2020Needham & Company LLCBoost Price TargetStrong-Buy$168.00 ➝ $185.00Low
12/15/2020Morgan StanleyBoost Price TargetOverweight$150.00 ➝ $170.00Low
12/15/2020The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyHigh
12/14/2020SVB LeerinkBoost Price TargetOutperform$167.00 ➝ $175.00Low
11/9/2020OppenheimerBoost Price TargetOutperform$150.00 ➝ $155.00Medium
11/9/2020Credit Suisse GroupBoost Price TargetUnderperform$99.00 ➝ $106.00High
11/9/2020SVB LeerinkBoost Price TargetOutperform$160.00 ➝ $167.00High
10/27/2020CowenBoost Price TargetPositive ➝ Market Perform$130.00 ➝ $150.00High
10/20/2020Northland SecuritiesInitiated CoverageMarket Perform$150.00Low
10/12/2020Raymond JamesBoost Price TargetStrong-Buy$150.00 ➝ $170.00Low
10/5/2020SVB LeerinkBoost Price TargetOutperform$153.00 ➝ $160.00Medium
9/11/2020Wolfe ResearchInitiated CoverageOutperform$174.00Low
9/4/2020ArgusBoost Price Target$145.00 ➝ $160.00Low
8/18/2020Morgan StanleyReiterated RatingBuy$150.00Medium
8/5/2020Credit Suisse GroupReiterated RatingSell$99.00Low
8/5/2020Morgan StanleyBoost Price TargetOverweight$140.00 ➝ $150.00Low
8/5/2020OppenheimerBoost Price TargetOutperform$138.00 ➝ $150.00Medium
8/5/2020SVB LeerinkBoost Price TargetOutperform$146.00 ➝ $153.00Medium
8/5/2020Raymond JamesBoost Price TargetStrong-Buy$140.00 ➝ $150.00Low
8/5/2020CitigroupBoost Price TargetBuy$140.00 ➝ $155.00Low
8/4/2020Needham & Company LLCInitiated CoverageStrong-Buy$148.00 ➝ $162.00Low
8/4/2020BTIG ResearchReiterated RatingBuy$139.00Medium
8/4/2020OppenheimerReiterated RatingBuy$138.00Medium
7/15/2020SVB LeerinkBoost Price TargetOutperform$136.00 ➝ $146.00High
5/28/2020OppenheimerInitiated CoverageBuy$138.00Low
5/18/2020JMP SecuritiesLower Price TargetPositive ➝ Outperform$175.00 ➝ $150.00High
5/12/2020Canaccord GenuityBoost Price TargetBuy$135.00 ➝ $137.00High
5/12/2020UBS GroupLower Price TargetBuy$180.00 ➝ $165.00High
5/12/2020Stifel NicolausBoost Price TargetBuy$111.00 ➝ $130.00High
5/12/2020SunTrust BanksBoost Price TargetBuy$125.00 ➝ $132.00High
5/12/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$160.00 ➝ $146.00High
5/12/2020Wells Fargo & CompanyBoost Price TargetOverweight$124.00 ➝ $132.00High
5/12/2020SVB LeerinkBoost Price TargetOutperform$130.00 ➝ $136.00High
5/12/2020Raymond JamesBoost Price TargetStrong-Buy$136.00 ➝ $140.00High
5/12/2020CitigroupBoost Price TargetBuy$125.00 ➝ $140.00High
5/11/2020OppenheimerLower Price TargetOutperform$141.00 ➝ $138.00High
5/11/2020Wells Fargo & CompanyReiterated RatingBuyHigh
5/11/2020Piper SandlerLower Price TargetIn-Line ➝ Overweight$175.00 ➝ $160.00High
5/11/2020Needham & Company LLCLower Price TargetStrong-Buy$153.00 ➝ $148.00Medium
4/28/2020OppenheimerLower Price TargetOutperform$175.00 ➝ $141.00Medium
4/28/2020GuggenheimDowngradeBuy ➝ NeutralMedium
4/19/2020Evercore ISIDowngradeOutperform ➝ In-LineMedium
4/13/2020Raymond JamesLower Price TargetStrong-Buy$190.00 ➝ $136.00Low
4/7/2020SVB LeerinkBoost Price TargetOutperform$121.00 ➝ $130.00High
4/7/2020SunTrust BanksLower Price TargetBuy$179.00 ➝ $125.00High
4/7/2020BTIG ResearchLower Price TargetBuy$170.00 ➝ $130.00Low
4/7/2020Needham & Company LLCLower Price TargetStrong-Buy$189.00 ➝ $153.00High
3/27/2020Morgan StanleyLower Price TargetOverweight$175.00 ➝ $140.00Low
3/27/2020CitigroupLower Price TargetBuy$168.00 ➝ $125.00High
3/25/2020SVB LeerinkLower Price TargetOutperform$181.00 ➝ $121.00High
3/24/2020Stifel NicolausLower Price TargetBuy$180.00 ➝ $93.00High
3/6/2020Credit Suisse GroupLower Price TargetOutperform$125.00 ➝ $115.00High
3/4/2020CitigroupInitiated CoverageBuy$168.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$177.00Low
2/6/2020JMP SecuritiesReiterated RatingAverage ➝ Outperform$175.00Low
2/5/2020OppenheimerBoost Price Target$165.00 ➝ $175.00Low
2/5/2020Robert W. BairdBoost Price TargetOutperform$161.00 ➝ $172.00Low
2/5/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$144.00 ➝ $160.00Low
2/5/2020Credit Suisse GroupBoost Price TargetUnderperform$120.00 ➝ $125.00Low
2/5/2020BTIG ResearchReiterated RatingBuy$170.00Low
2/5/2020Morgan StanleyBoost Price TargetOverweight$170.00 ➝ $175.00Low
2/5/2020Raymond JamesBoost Price TargetPositive ➝ Strong-Buy$170.00 ➝ $190.00Low
2/4/2020Piper SandlerBoost Price TargetOverweight$170.00 ➝ $175.00Low
2/4/2020Needham & Company LLCReiterated RatingStrong-Buy$187.00 ➝ $189.00High
1/10/2020Wells Fargo & CompanyBoost Price TargetOverweight$165.00 ➝ $170.00Medium
1/7/2020SunTrust BanksInitiated CoverageBuy$179.00Medium
1/7/2020Piper SandlerUpgradeNeutral ➝ Overweight$140.00 ➝ $170.00Low
1/7/2020Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$140.00 ➝ $170.00Low
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$108.00Low
1/2/2020CitigroupUpgradeNeutral ➝ BuyLow
12/19/2019Needham & Company LLCBoost Price TargetStrong-Buy$170.00 ➝ $187.00Low
12/17/2019Morgan StanleyBoost Price TargetOverweight$150.00 ➝ $170.00Low
12/12/2019Wells Fargo & CompanyBoost Price TargetOverweight$158.00 ➝ $165.00Low
12/9/2019Wells Fargo & CompanyReiterated RatingBuyMedium
12/4/2019Raymond JamesUpgradeOutperform ➝ Strong-Buy$160.00 ➝ $170.00High
11/6/2019Royal Bank of CanadaBoost Price TargetOutperform$145.00 ➝ $155.00Low
11/6/2019Raymond JamesBoost Price TargetOutperform$150.00 ➝ $160.00Medium
11/6/2019SVB LeerinkBoost Price TargetOutperform$155.00 ➝ $160.00Medium
11/5/2019Needham & Company LLCReiterated RatingBuy$170.00Medium
10/7/2019BTIG ResearchUpgradeNeutral ➝ Buy$158.00Low
9/23/2019CowenSet Price TargetBuy$140.00Medium
9/18/2019Needham & Company LLCReiterated RatingBuy$170.00Medium
9/18/2019Canaccord GenuityUpgradeHold ➝ Buy$137.00 ➝ $167.00Medium
9/17/2019Stifel NicolausSet Price TargetBuy$155.00Low
9/16/2019BTIG ResearchReiterated RatingHoldLow
9/9/2019Wells Fargo & CompanyBoost Price TargetOutperform$150.00 ➝ $158.00Medium
8/12/2019ArgusUpgradeHold ➝ Buy$160.00Low
8/2/2019CitigroupBoost Price TargetBuy$146.00 ➝ $158.00Low
7/30/2019BarclaysUpgradeUnderweight ➝ Equal Weight$117.00 ➝ $140.00Low
7/29/2019OppenheimerBoost Price TargetOutperform$135.00 ➝ $150.00Low
7/29/2019Morgan StanleyBoost Price TargetOverweight$143.00 ➝ $150.00Low
7/29/2019Wells Fargo & CompanyBoost Price TargetOutperform$143.00 ➝ $150.00Low
7/29/2019Raymond JamesBoost Price TargetOutperform$145.00 ➝ $150.00Low
7/29/2019Credit Suisse GroupBoost Price TargetUnderperform$101.00 ➝ $120.00Low
7/29/2019Jefferies Financial GroupBoost Price TargetBuy$150.00 ➝ $167.00Low
7/29/2019Robert W. BairdUpgradeNeutral ➝ Outperform$132.00 ➝ $154.00Low
7/26/2019CowenSet Price TargetHold$140.00N/A
6/11/2019Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform$121.71Low
4/26/2019Cantor FitzgeraldSet Price TargetBuy$135.00Low
4/24/2019Needham & Company LLCUpgradeBuy ➝ Strong-Buy$146.00 ➝ $155.00Low
4/15/2019BarclaysBoost Price TargetUnderweight ➝ Underweight$113.00 ➝ $117.00Low
4/8/2019Evercore ISIUpgradeIn-Line ➝ Outperform$145.00Low
3/4/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$132.00 ➝ $143.00Low
2/5/2019BarclaysSet Price TargetSell$113.00Low
2/5/2019SunTrust BanksBoost Price TargetBuy$135.00Low
2/2/2019OppenheimerReiterated RatingBuyLow
1/25/2019Cantor FitzgeraldSet Price TargetBuy$135.00Low
1/22/2019Stifel NicolausLower Price TargetBuy$150.00 ➝ $135.00Low
1/18/2019Cantor FitzgeraldSet Price TargetBuy$135.00Medium
1/15/2019Cantor FitzgeraldReiterated RatingOverweightN/A
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$108.00Medium
1/2/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$149.00 ➝ $126.00Low
1/2/2019CitigroupUpgradeNeutral ➝ Buy$122.00 ➝ $127.00Low
12/19/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$140.00 ➝ $118.00Low
12/17/2018Credit Suisse GroupInitiated CoverageUnderperform$102.00Medium
12/6/2018OppenheimerSet Price TargetBuy$135.00Low
11/27/2018UBS GroupInitiated CoverageBuy ➝ Buy$140.00High
10/29/2018SVB LeerinkLower Price TargetOutperform$146.00 ➝ $141.00Low
10/29/2018Jefferies Financial GroupLower Price TargetBuy ➝ Buy$145.00 ➝ $140.00Low
10/29/2018CitigroupLower Price TargetNeutral ➝ Neutral$129.00 ➝ $122.00Medium
10/29/2018BarclaysLower Price TargetUnderweight ➝ Sell$131.00 ➝ $119.00Medium
10/29/2018OppenheimerSet Price TargetBuy$135.00Low
10/28/2018BTIG ResearchReiterated RatingHoldLow
10/15/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$131.00High
10/11/2018Morgan StanleyBoost Price TargetOverweight$140.00 ➝ $149.00High
8/27/2018OppenheimerReiterated RatingBuyLow
8/27/2018Needham & Company LLCReiterated RatingBuy$150.00High
8/27/2018Cantor FitzgeraldReiterated RatingBuy$150.00High
8/16/2018BTIG ResearchInitiated CoverageNeutralLow
8/13/2018Needham & Company LLCDowngradeStrong-Buy ➝ Buy$150.00Low
7/31/2018CitigroupBoost Price TargetNeutral ➝ Neutral$117.00 ➝ $128.00Low
7/30/2018Jefferies Financial GroupBoost Price TargetBuy$145.00Low
7/30/2018Piper Jaffray CompaniesBoost Price TargetNeutral$110.00 ➝ $120.00Low
7/30/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$121.00 ➝ $132.00Low
7/30/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$135.00 ➝ $145.00Low
7/30/2018Needham & Company LLCBoost Price TargetStrong-Buy$146.00 ➝ $150.00Medium
7/30/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$140.00 ➝ $150.00Medium
7/30/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Outperform$133.00 ➝ $140.00Medium
7/30/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$122.00 ➝ $125.00Medium
7/27/2018OppenheimerReiterated RatingBuy$130.00 ➝ $138.00High
6/27/2018Sanford C. BernsteinInitiated CoverageUnderperform$96.00High
6/22/2018ArgusDowngradeBuy ➝ HoldHigh
4/27/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$148.00 ➝ $140.00Low
4/27/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$145.00 ➝ $133.00Low
4/27/2018Needham & Company LLCLower Price TargetStrong-Buy ➝ Strong-Buy$155.00 ➝ $146.00Medium
4/12/2018Canaccord GenuityReiterated RatingHold$121.00Low
4/2/2018Evercore ISIInitiated CoverageIn-Line$115.00Low
3/23/2018Robert W. BairdDowngradeOutperform ➝ NeutralHigh
3/15/2018OppenheimerInitiated CoverageOutperform$135.00Low
3/15/2018Raymond JamesInitiated CoverageOutperform$135.00Low
2/27/2018CitigroupLower Price TargetNeutral ➝ Neutral$132.00 ➝ $121.00Low
2/26/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$150.00 ➝ $148.00Low
2/5/2018Cantor FitzgeraldReiterated RatingBuy$140.00High
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$142.00 ➝ $146.00Low
1/31/2018Stifel NicolausUpgradeHold ➝ Buy$120.00 ➝ $168.00Low
1/31/2018Robert W. BairdReiterated RatingBuyLow
1/30/2018BMO Capital MarketsReiterated RatingBuy$144.00Low
1/30/2018Cantor FitzgeraldReiterated RatingBuy$140.00Low
1/30/2018Needham & Company LLCBoost Price TargetStrong-Buy ➝ Strong-Buy$144.00 ➝ $155.00Medium
1/29/2018SunTrust BanksBoost Price TargetBuy$142.00Medium
1/29/2018Morgan StanleyBoost Price Target$140.00 ➝ $150.00Medium
1/5/2018Canaccord GenuityReiterated RatingHold$132.00Low
1/5/2018Cantor FitzgeraldReiterated RatingOverweight ➝ OverweightLow
12/19/2017The Goldman Sachs GroupUpgradeSell ➝ Neutral$125.00Low
12/19/2017Canaccord GenuityReiterated RatingHold$125.00Low
12/19/2017OppenheimerReiterated RatingBuyMedium
12/19/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformLow
12/12/2017BMO Capital MarketsReiterated RatingBuy$142.00Low
11/14/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$128.00N/A
11/9/2017Edward JonesUpgradeHold ➝ BuyN/A
11/7/2017Royal Bank of CanadaLower Price TargetOutperform$125.00N/A
11/3/2017Stifel NicolausReiterated RatingHold$120.00N/A
11/3/2017Jefferies Financial GroupReiterated RatingBuy$136.00N/A
11/2/2017Morgan StanleyLower Price TargetOverweight$146.00 ➝ $136.00N/A
11/2/2017BMO Capital MarketsLower Price TargetOutperform$140.00 ➝ $135.00N/A
11/2/2017Piper Jaffray CompaniesDowngradeOverweight ➝ NeutralN/A
11/1/2017SunTrust BanksSet Price TargetBuy$136.00N/A
10/2/2017SunTrust BanksReiterated RatingBuy$136.00Low
8/24/2017GabelliInitiated CoverageBuy$142.00Low
8/14/2017OppenheimerSet Price TargetBuy$137.00Low
7/28/2017BMO Capital MarketsBoost Price TargetOutperform$136.00 ➝ $140.00Low
7/28/2017SVB LeerinkBoost Price TargetOutperform$141.00 ➝ $146.00Low
7/28/2017OppenheimerSet Price TargetBuy$137.00Medium
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$135.00Medium
7/28/2017Canaccord GenuityDowngradeBuy ➝ Hold$141.00 ➝ $135.00Medium
7/27/2017Cantor FitzgeraldSet Price TargetHold$137.00Low
7/17/2017Morgan StanleyBoost Price TargetOverweight$137.00 ➝ $150.00Low
7/14/2017Piper Jaffray CompaniesReiterated RatingBuy$141.00Low
7/14/2017Stifel NicolausReiterated RatingHold$125.00Low
7/14/2017Bank of AmericaReiterated RatingBuy ➝ Buy$158.00Medium
7/14/2017Wells Fargo & CompanyReiterated RatingMarket WeightHigh
7/14/2017Royal Bank of CanadaReiterated RatingOutperform$140.00High
7/14/2017Canaccord GenuityReiterated RatingBuy$141.00High
7/12/2017Needham & Company LLCReiterated RatingStrong-Buy$153.00Low
7/12/2017GuggenheimUpgradeNeutral ➝ Buy$157.00Medium
7/11/2017BMO Capital MarketsReiterated RatingBuy$136.00Low
6/30/2017Jefferies Financial GroupReiterated RatingBuy$148.00Low
6/29/2017Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$137.00Low
6/21/2017Royal Bank of CanadaBoost Price TargetOutperform$133.00 ➝ $140.00Medium
6/9/2017CitigroupBoost Price TargetNeutral$108.00 ➝ $130.00Low
5/16/2017The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$92.00High
4/28/2017Canaccord GenuityReiterated RatingBuyLow
4/28/2017OppenheimerSet Price TargetBuy$132.00Low
4/28/2017Needham & Company LLCBoost Price TargetStrong-Buy ➝ Strong-Buy$151.00 ➝ $153.00Medium
4/28/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformMedium
3/14/2017Royal Bank of CanadaReiterated RatingBuy$133.00Medium
2/17/2017Needham & Company LLCReiterated RatingStrong-Buy$151.00N/A
2/1/2017OppenheimerSet Price TargetBuy$126.00 ➝ $132.00N/A
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 ➝ $136.00N/A
2/1/2017Royal Bank of CanadaBoost Price TargetOutperform$130.00 ➝ $133.00N/A
1/31/2017Canaccord GenuitySet Price TargetBuy$144.00N/A
1/25/2017Needham & Company LLCBoost Price TargetStrong-Buy$148.00 ➝ $151.00N/A
1/23/2017Canaccord GenuitySet Price TargetBuy$130.00N/A
1/5/2017JPMorgan Chase & Co.Set Price TargetBuy$134.00N/A
12/21/2016UBS GroupDowngradeNeutral ➝ Sell$113.00 ➝ $100.00N/A
12/15/2016UBS GroupDowngradeNeutral ➝ SellN/A
12/15/2016Needham & Company LLCReiterated RatingBuy$148.00N/A
11/29/2016CitigroupUpgradeSell ➝ NeutralN/A
11/8/2016Northcoast ResearchDowngradeBuy ➝ NeutralN/A
11/1/2016SVB LeerinkReiterated RatingOutperform$150.00 ➝ $136.00N/A
11/1/2016Royal Bank of CanadaReiterated RatingOutperform$143.00 ➝ $130.00N/A
11/1/2016Royal Bank of CanadaLower Price TargetOutperform$143.00 ➝ $130.00N/A
11/1/2016Needham & Company LLCUpgradeBuy ➝ Strong-Buy$150.00 ➝ $148.00N/A
11/1/2016Jefferies Financial GroupLower Price TargetBuy$150.00 ➝ $129.00N/A
10/31/2016Canaccord GenuityReiterated RatingBuy$150.00 ➝ $130.00N/A
9/22/2016ArgusReiterated RatingBuy$140.00N/A
9/14/2016Royal Bank of CanadaSet Price TargetBuy$143.00N/A
8/23/2016BarclaysBoost Price TargetOverweight$140.00 ➝ $145.00N/A
8/11/2016SunTrust BanksInitiated CoverageBuy$155.00N/A
8/10/2016SunTrust BanksInitiated CoverageBuyN/A
8/8/2016Jefferies Financial GroupReiterated RatingBuy$150.00N/A
8/2/2016UBS GroupReiterated RatingNeutral$117.00 ➝ $132.00N/A
7/29/2016BMO Capital MarketsReiterated RatingBuy$146.00N/A
7/29/2016JPMorgan Chase & Co.Boost Price TargetOverweight$134.00 ➝ $148.00N/A
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 ➝ $145.00N/A
7/29/2016Jefferies Financial GroupBoost Price TargetBuy$135.00 ➝ $150.00N/A
7/29/2016CitigroupBoost Price TargetSell$91.00 ➝ $95.00N/A
7/29/2016BarclaysBoost Price TargetOverweight$135.00 ➝ $140.00N/A
7/29/2016Needham & Company LLCBoost Price TargetBuy$143.00 ➝ $150.00N/A
7/18/2016Needham & Company LLCReiterated RatingBuy$134.00 ➝ $143.00N/A
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$125.00N/A
(Data available from 6/21/2016 forward)
Zimmer Biomet logo
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Read More

Today's Range

Now: $163.48
Low: $158.77
High: $164.07

50 Day Range

MA: $167.72
Low: $157.54
High: $178.61

52 Week Range

Now: $163.48
Low: $112.00
High: $180.36

Volume

1,580,142 shs

Average Volume

1,213,864 shs

Market Capitalization

$34.08 billion

P/E Ratio

60.77

Dividend Yield

0.61%

Beta

1.35

Frequently Asked Questions

What sell-side analysts currently cover shares of Zimmer Biomet?

The following sell-side analysts have issued stock ratings on Zimmer Biomet in the last year: Argus, Barclays PLC, BTIG Research, Canaccord Genuity, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, JMP Securities, Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Financial Co., Truist Securities, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for ZBH.

What is the current price target for Zimmer Biomet?

22 Wall Street analysts have set twelve-month price targets for Zimmer Biomet in the last year. Their average twelve-month price target is $179.91, suggesting a possible upside of 13.5%. Barclays PLC has the highest price target set, predicting ZBH will reach $210.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $106.00 for Zimmer Biomet in the next year.
View the latest price targets for ZBH.

What is the current consensus analyst rating for Zimmer Biomet?

Zimmer Biomet currently has 1 sell rating, 2 hold ratings, 14 buy ratings and 3 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ZBH will outperform the market and that investors should add to their positions of Zimmer Biomet.
View the latest ratings for ZBH.

What other companies compete with Zimmer Biomet?

How do I contact Zimmer Biomet's investor relations team?

Zimmer Biomet's physical mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider's listed phone number is (574) 267-6131 and its investor relations email address is [email protected] The official website for Zimmer Biomet is www.zimmerbiomet.com.